By Diagnostics World Staff
December 9, 2016 | Novogene, AITbiotech, and the Genome Institute of Singapore (GIS) announced today that NovogeneAIT Genomics Singapore (NovogeneAIT), a new joint venture between Novogene and AITbiotech, will establish a joint whole genome sequencing (WGS) center at Biopolis, Singapore.
Novogene is a provider of genomic services and solutions with NGS and bioinformatics expertise and one of the largest sequencing capacities in the world, covered in a profile by Diagnostics World.
The new center will provide Illumina HiSeq X based WGS and bioinformatics analysis of human, plant, and animal samples for biomedical and agricultural researchers. The center will devote a major portion of its sequencing capability to support public research projects and empower super scale sequencing initiatives in Singapore and the region. In addition, NovogeneAIT will collaborate with GIS to develop new applications of next-generation sequencing, such as WGS solutions for cancer diagnosis and stratified cancer treatment.
“We are delighted to work with a local biotech company,” said Ng Huck Hui, Executive Director of GIS in a statement. “Such public-private partnerships will prove to be highly beneficial as it leverages the strengths of both parties to advance genomic science and medicine in Singapore, as well as to create successful local biotech companies.”